Clinical Pathways Search Results

This pathway is intended for Emergency Department patients requiring procedural sedation who are healthy or those with mild systemic disease that is well controlled.

Treatment for the hospitalized Sickle Cell patient with Acute Chest Syndrome.

The bronchiolitis pathway details the steps necessary in the assessment and treatment of a child with bronchiolitis in an inpatient setting.

The inhaled nitric oxide pathway takes a step-by-step approach to the initiation and management of nitric oxide in newborns with persistent pulmonary hypertension.

The Outpatient Specialty Care and Primary Care Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.

The ED Coronavirus Pathway provides guidance for the evaluation and care of patients with laboratory-confirmed 2019-nCoV or who is under investigation for 2019-nCoV while that patient was ill.

Treatment of patients with active COVID-19 disease with guidance on severity of illness, recommendations for antivirals, steroids, immunomodulators, and convalescent plasma administration.

The Beckwith-Wiedemann Syndrome (BWS) Clinical Pathway provides guidance of care for neonates/infants born at the CHOP SDU or referred from outside institutions for further evaluation and treatment with overgrowth features such as macroglossia, hyperinsulinism, omphalocele and/or a constellation of findings suspicious for BWS.

This pathway provides a detailed overview of preoperative, intraoperative, and postoperative care for the infant diagnosed with CDH during their initial hospitalization.  

The CICU pathway for ventilator weaning provides guidance on the management and weaning of conventional mechanical ventilation and extubation readiness in children in the Cardiac Intensive Care Unit.